ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global BCG Tuberculosis Vaccine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-2X8244
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global BCG and Tuberculosis Vaccine Market Research Report 2022
BUY CHAPTERS

Global BCG Tuberculosis Vaccine Market Research Report 2025

Code: QYRE-Auto-2X8244
Report
July 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Japan BCG Lab
China National Biotec
Serum Institute of India
AJ Vaccines
Biofarma
GreenSignal Bio Pharma
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC-Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Fundação Ataulpho de Paiva

BCG Tuberculosis Vaccine Market Size

The global market for BCG Tuberculosis Vaccine was valued at US$ 80.4 million in the year 2024 and is projected to reach a revised size of US$ 99 million by 2031, growing at a CAGR of 3.1% during the forecast period.

BCG Tuberculosis Vaccine Market

BCG Tuberculosis Vaccine Market

The BCG (Bacillus Calmette-Guérin) vaccine is primarily used to prevent tuberculosis (TB) and is administered in countries with a high incidence of TB. It is made from a weakened strain of Mycobacterium bovis, a bacterium closely related to Mycobacterium tuberculosis, which causes TB. The vaccine is particularly effective against severe forms of TB in children, such as TB meningitis. Although its effectiveness varies in preventing adult pulmonary TB, it remains a critical tool in TB control programs worldwide.
Market Drivers for BCG Tuberculosis Vaccine
High TB Prevalence in Developing Countries: The BCG vaccine is primarily administered in countries with high tuberculosis (TB) incidence, especially in regions like Asia, Africa, and parts of Latin America. The ongoing prevalence of TB in these regions creates sustained demand for the vaccine.
Government Vaccination Programs: Many countries include the BCG vaccine in their national immunization programs, often making it mandatory for newborns. These government initiatives ensure consistent demand for the vaccine and steady growth in the market.
Rising Awareness and Health Initiatives: Increased awareness of TB prevention and new health programs, driven by the World Health Organization (WHO) and other agencies, have heightened the focus on TB prevention. These efforts emphasize the importance of BCG vaccination in controlling TB transmission.
Increased Focus on Pediatric Vaccination: Since TB poses a high risk to children, especially in severe forms like TB meningitis, health organizations prioritize BCG vaccination for newborns and young children. This prioritization supports a stable pediatric vaccine demand, especially in high-burden countries.
Market Challenges for BCG Tuberculosis Vaccine
Varying Vaccine Efficacy: BCG's effectiveness against adult pulmonary TB varies widely depending on factors such as geographic location and TB strain types, limiting its use in countries with low TB prevalence. This variability in efficacy reduces the global reach and perceived reliability of the vaccine.
Supply Chain and Production Constraints: Production of BCG vaccine involves complex manufacturing processes, and any disruption—such as shortages of raw materials or production facility issues—can impact supply. This challenge can lead to supply bottlenecks, especially in low-income countries reliant on imports.
Competition with Newer TB Vaccines in Development: Advances in TB research are driving the development of new vaccines that may be more effective in preventing pulmonary TB in adults. If these newer vaccines become available, they may reduce the demand for BCG in countries with access to better alternatives.
Decline in TB Incidence in Developed Regions: In regions with low TB prevalence, such as North America and parts of Europe, the BCG vaccine is rarely used due to a low risk of infection. This regional decline in demand limits the market potential for BCG in more developed countries.

Report Scope

This report aims to provide a comprehensive presentation of the global market for BCG Tuberculosis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCG Tuberculosis Vaccine.
The BCG Tuberculosis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global BCG Tuberculosis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the BCG Tuberculosis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of BCG Tuberculosis Vaccine Market Report

Report Metric Details
Report Name BCG Tuberculosis Vaccine Market
Accounted market size in year US$ 80.4 million
Forecasted market size in 2031 US$ 99 million
CAGR 3.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • BCG Immunization
  • BCG Treatment
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, IVAC – Institute of Vaccines and Medical Biologicals, Queen Saovabha Mem. Inst, Microgen, Fundação Ataulpho de Paiva
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of BCG Tuberculosis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of BCG Tuberculosis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is BCG Tuberculosis Vaccine Market growing?

Ans: The BCG Tuberculosis Vaccine Market witnessing a CAGR of 3.1% during the forecast period 2025-2031.

What is the BCG Tuberculosis Vaccine Market size in 2031?

Ans: The BCG Tuberculosis Vaccine Market size in 2031 will be US$ 99 million.

Who are the main players in the BCG Tuberculosis Vaccine Market report?

Ans: The main players in the BCG Tuberculosis Vaccine Market are Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, IVAC – Institute of Vaccines and Medical Biologicals, Queen Saovabha Mem. Inst, Microgen, Fundação Ataulpho de Paiva

What are the Application segmentation covered in the BCG Tuberculosis Vaccine Market report?

Ans: The Applications covered in the BCG Tuberculosis Vaccine Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the BCG Tuberculosis Vaccine Market report?

Ans: The Types covered in the BCG Tuberculosis Vaccine Market report are BCG Immunization, BCG Treatment

1 BCG Tuberculosis Vaccine Market Overview
1.1 Product Definition
1.2 BCG Tuberculosis Vaccine by Type
1.2.1 Global BCG Tuberculosis Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 BCG Immunization
1.2.3 BCG Treatment
1.3 BCG Tuberculosis Vaccine by Application
1.3.1 Global BCG Tuberculosis Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global BCG Tuberculosis Vaccine Market Size Estimates and Forecasts
1.4.1 Global BCG Tuberculosis Vaccine Revenue 2020-2031
1.4.2 Global BCG Tuberculosis Vaccine Sales 2020-2031
1.4.3 Global BCG Tuberculosis Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 BCG Tuberculosis Vaccine Market Competition by Manufacturers
2.1 Global BCG Tuberculosis Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global BCG Tuberculosis Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global BCG Tuberculosis Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of BCG Tuberculosis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of BCG Tuberculosis Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of BCG Tuberculosis Vaccine, Product Type & Application
2.7 Global Key Manufacturers of BCG Tuberculosis Vaccine, Date of Enter into This Industry
2.8 Global BCG Tuberculosis Vaccine Market Competitive Situation and Trends
2.8.1 Global BCG Tuberculosis Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest BCG Tuberculosis Vaccine Players Market Share by Revenue
2.8.3 Global BCG Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global BCG Tuberculosis Vaccine Market Scenario by Region
3.1 Global BCG Tuberculosis Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global BCG Tuberculosis Vaccine Sales by Region: 2020-2031
3.2.1 Global BCG Tuberculosis Vaccine Sales by Region: 2020-2025
3.2.2 Global BCG Tuberculosis Vaccine Sales by Region: 2026-2031
3.3 Global BCG Tuberculosis Vaccine Revenue by Region: 2020-2031
3.3.1 Global BCG Tuberculosis Vaccine Revenue by Region: 2020-2025
3.3.2 Global BCG Tuberculosis Vaccine Revenue by Region: 2026-2031
3.4 North America BCG Tuberculosis Vaccine Market Facts & Figures by Country
3.4.1 North America BCG Tuberculosis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America BCG Tuberculosis Vaccine Sales by Country (2020-2031)
3.4.3 North America BCG Tuberculosis Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe BCG Tuberculosis Vaccine Market Facts & Figures by Country
3.5.1 Europe BCG Tuberculosis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe BCG Tuberculosis Vaccine Sales by Country (2020-2031)
3.5.3 Europe BCG Tuberculosis Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific BCG Tuberculosis Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific BCG Tuberculosis Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific BCG Tuberculosis Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific BCG Tuberculosis Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America BCG Tuberculosis Vaccine Market Facts & Figures by Country
3.7.1 Latin America BCG Tuberculosis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America BCG Tuberculosis Vaccine Sales by Country (2020-2031)
3.7.3 Latin America BCG Tuberculosis Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa BCG Tuberculosis Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa BCG Tuberculosis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa BCG Tuberculosis Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa BCG Tuberculosis Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global BCG Tuberculosis Vaccine Sales by Type (2020-2031)
4.1.1 Global BCG Tuberculosis Vaccine Sales by Type (2020-2025)
4.1.2 Global BCG Tuberculosis Vaccine Sales by Type (2026-2031)
4.1.3 Global BCG Tuberculosis Vaccine Sales Market Share by Type (2020-2031)
4.2 Global BCG Tuberculosis Vaccine Revenue by Type (2020-2031)
4.2.1 Global BCG Tuberculosis Vaccine Revenue by Type (2020-2025)
4.2.2 Global BCG Tuberculosis Vaccine Revenue by Type (2026-2031)
4.2.3 Global BCG Tuberculosis Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global BCG Tuberculosis Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global BCG Tuberculosis Vaccine Sales by Application (2020-2031)
5.1.1 Global BCG Tuberculosis Vaccine Sales by Application (2020-2025)
5.1.2 Global BCG Tuberculosis Vaccine Sales by Application (2026-2031)
5.1.3 Global BCG Tuberculosis Vaccine Sales Market Share by Application (2020-2031)
5.2 Global BCG Tuberculosis Vaccine Revenue by Application (2020-2031)
5.2.1 Global BCG Tuberculosis Vaccine Revenue by Application (2020-2025)
5.2.2 Global BCG Tuberculosis Vaccine Revenue by Application (2026-2031)
5.2.3 Global BCG Tuberculosis Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global BCG Tuberculosis Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck BCG Tuberculosis Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Japan BCG Lab
6.2.1 Japan BCG Lab Company Information
6.2.2 Japan BCG Lab Description and Business Overview
6.2.3 Japan BCG Lab BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Japan BCG Lab BCG Tuberculosis Vaccine Product Portfolio
6.2.5 Japan BCG Lab Recent Developments/Updates
6.3 Serum Institute of India
6.3.1 Serum Institute of India Company Information
6.3.2 Serum Institute of India Description and Business Overview
6.3.3 Serum Institute of India BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Serum Institute of India BCG Tuberculosis Vaccine Product Portfolio
6.3.5 Serum Institute of India Recent Developments/Updates
6.4 AJ Vaccines
6.4.1 AJ Vaccines Company Information
6.4.2 AJ Vaccines Description and Business Overview
6.4.3 AJ Vaccines BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AJ Vaccines BCG Tuberculosis Vaccine Product Portfolio
6.4.5 AJ Vaccines Recent Developments/Updates
6.5 BioFarma
6.5.1 BioFarma Company Information
6.5.2 BioFarma Description and Business Overview
6.5.3 BioFarma BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BioFarma BCG Tuberculosis Vaccine Product Portfolio
6.5.5 BioFarma Recent Developments/Updates
6.6 GreenSignal Bio Pharma
6.6.1 GreenSignal Bio Pharma Company Information
6.6.2 GreenSignal Bio Pharma Description and Business Overview
6.6.3 GreenSignal Bio Pharma BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GreenSignal Bio Pharma BCG Tuberculosis Vaccine Product Portfolio
6.6.5 GreenSignal Bio Pharma Recent Developments/Updates
6.7 China National Biotec
6.7.1 China National Biotec Company Information
6.7.2 China National Biotec Description and Business Overview
6.7.3 China National Biotec BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 China National Biotec BCG Tuberculosis Vaccine Product Portfolio
6.7.5 China National Biotec Recent Developments/Updates
6.8 Biomed Lublin
6.8.1 Biomed Lublin Company Information
6.8.2 Biomed Lublin Description and Business Overview
6.8.3 Biomed Lublin BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biomed Lublin BCG Tuberculosis Vaccine Product Portfolio
6.8.5 Biomed Lublin Recent Developments/Updates
6.9 Taj Pharmaceuticals
6.9.1 Taj Pharmaceuticals Company Information
6.9.2 Taj Pharmaceuticals Description and Business Overview
6.9.3 Taj Pharmaceuticals BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Taj Pharmaceuticals BCG Tuberculosis Vaccine Product Portfolio
6.9.5 Taj Pharmaceuticals Recent Developments/Updates
6.10 Ataulpho de Paiva
6.10.1 Ataulpho de Paiva Company Information
6.10.2 Ataulpho de Paiva Description and Business Overview
6.10.3 Ataulpho de Paiva BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ataulpho de Paiva BCG Tuberculosis Vaccine Product Portfolio
6.10.5 Ataulpho de Paiva Recent Developments/Updates
6.11 IVAC – Institute of Vaccines and Medical Biologicals
6.11.1 IVAC – Institute of Vaccines and Medical Biologicals Company Information
6.11.2 IVAC – Institute of Vaccines and Medical Biologicals Description and Business Overview
6.11.3 IVAC – Institute of Vaccines and Medical Biologicals BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 IVAC – Institute of Vaccines and Medical Biologicals BCG Tuberculosis Vaccine Product Portfolio
6.11.5 IVAC – Institute of Vaccines and Medical Biologicals Recent Developments/Updates
6.12 Queen Saovabha Mem. Inst
6.12.1 Queen Saovabha Mem. Inst Company Information
6.12.2 Queen Saovabha Mem. Inst Description and Business Overview
6.12.3 Queen Saovabha Mem. Inst BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Queen Saovabha Mem. Inst BCG Tuberculosis Vaccine Product Portfolio
6.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
6.13 Microgen
6.13.1 Microgen Company Information
6.13.2 Microgen Description and Business Overview
6.13.3 Microgen BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Microgen BCG Tuberculosis Vaccine Product Portfolio
6.13.5 Microgen Recent Developments/Updates
6.14 Fundação Ataulpho de Paiva
6.14.1 Fundação Ataulpho de Paiva Company Information
6.14.2 Fundação Ataulpho de Paiva Description and Business Overview
6.14.3 Fundação Ataulpho de Paiva BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Fundação Ataulpho de Paiva BCG Tuberculosis Vaccine Product Portfolio
6.14.5 Fundação Ataulpho de Paiva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 BCG Tuberculosis Vaccine Industry Chain Analysis
7.2 BCG Tuberculosis Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 BCG Tuberculosis Vaccine Production Mode & Process Analysis
7.4 BCG Tuberculosis Vaccine Sales and Marketing
7.4.1 BCG Tuberculosis Vaccine Sales Channels
7.4.2 BCG Tuberculosis Vaccine Distributors
7.5 BCG Tuberculosis Vaccine Customer Analysis
8 BCG Tuberculosis Vaccine Market Dynamics
8.1 BCG Tuberculosis Vaccine Industry Trends
8.2 BCG Tuberculosis Vaccine Market Drivers
8.3 BCG Tuberculosis Vaccine Market Challenges
8.4 BCG Tuberculosis Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
Japan BCG Lab
China National Biotec
Serum Institute of India
AJ Vaccines
Biofarma
GreenSignal Bio Pharma
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC-Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Fundação Ataulpho de Paiva
List of Tables
 Table 1. Global BCG Tuberculosis Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global BCG Tuberculosis Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global BCG Tuberculosis Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global BCG Tuberculosis Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global BCG Tuberculosis Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global BCG Tuberculosis Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global BCG Tuberculosis Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market BCG Tuberculosis Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of BCG Tuberculosis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of BCG Tuberculosis Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of BCG Tuberculosis Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of BCG Tuberculosis Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global BCG Tuberculosis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG Tuberculosis Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global BCG Tuberculosis Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global BCG Tuberculosis Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global BCG Tuberculosis Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global BCG Tuberculosis Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global BCG Tuberculosis Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global BCG Tuberculosis Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global BCG Tuberculosis Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global BCG Tuberculosis Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global BCG Tuberculosis Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America BCG Tuberculosis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America BCG Tuberculosis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America BCG Tuberculosis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America BCG Tuberculosis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America BCG Tuberculosis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe BCG Tuberculosis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe BCG Tuberculosis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe BCG Tuberculosis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe BCG Tuberculosis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe BCG Tuberculosis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific BCG Tuberculosis Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific BCG Tuberculosis Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific BCG Tuberculosis Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific BCG Tuberculosis Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific BCG Tuberculosis Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America BCG Tuberculosis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America BCG Tuberculosis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America BCG Tuberculosis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America BCG Tuberculosis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America BCG Tuberculosis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa BCG Tuberculosis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa BCG Tuberculosis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa BCG Tuberculosis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa BCG Tuberculosis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa BCG Tuberculosis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global BCG Tuberculosis Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global BCG Tuberculosis Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global BCG Tuberculosis Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global BCG Tuberculosis Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global BCG Tuberculosis Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global BCG Tuberculosis Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global BCG Tuberculosis Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global BCG Tuberculosis Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global BCG Tuberculosis Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global BCG Tuberculosis Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global BCG Tuberculosis Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global BCG Tuberculosis Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global BCG Tuberculosis Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global BCG Tuberculosis Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global BCG Tuberculosis Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global BCG Tuberculosis Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global BCG Tuberculosis Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global BCG Tuberculosis Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global BCG Tuberculosis Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global BCG Tuberculosis Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck BCG Tuberculosis Vaccine Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Japan BCG Lab Company Information
 Table 76. Japan BCG Lab Description and Business Overview
 Table 77. Japan BCG Lab BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Japan BCG Lab BCG Tuberculosis Vaccine Product
 Table 79. Japan BCG Lab Recent Developments/Updates
 Table 80. Serum Institute of India Company Information
 Table 81. Serum Institute of India Description and Business Overview
 Table 82. Serum Institute of India BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Serum Institute of India BCG Tuberculosis Vaccine Product
 Table 84. Serum Institute of India Recent Developments/Updates
 Table 85. AJ Vaccines Company Information
 Table 86. AJ Vaccines Description and Business Overview
 Table 87. AJ Vaccines BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. AJ Vaccines BCG Tuberculosis Vaccine Product
 Table 89. AJ Vaccines Recent Developments/Updates
 Table 90. BioFarma Company Information
 Table 91. BioFarma Description and Business Overview
 Table 92. BioFarma BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. BioFarma BCG Tuberculosis Vaccine Product
 Table 94. BioFarma Recent Developments/Updates
 Table 95. GreenSignal Bio Pharma Company Information
 Table 96. GreenSignal Bio Pharma Description and Business Overview
 Table 97. GreenSignal Bio Pharma BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. GreenSignal Bio Pharma BCG Tuberculosis Vaccine Product
 Table 99. GreenSignal Bio Pharma Recent Developments/Updates
 Table 100. China National Biotec Company Information
 Table 101. China National Biotec Description and Business Overview
 Table 102. China National Biotec BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. China National Biotec BCG Tuberculosis Vaccine Product
 Table 104. China National Biotec Recent Developments/Updates
 Table 105. Biomed Lublin Company Information
 Table 106. Biomed Lublin Description and Business Overview
 Table 107. Biomed Lublin BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Biomed Lublin BCG Tuberculosis Vaccine Product
 Table 109. Biomed Lublin Recent Developments/Updates
 Table 110. Taj Pharmaceuticals Company Information
 Table 111. Taj Pharmaceuticals Description and Business Overview
 Table 112. Taj Pharmaceuticals BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Taj Pharmaceuticals BCG Tuberculosis Vaccine Product
 Table 114. Taj Pharmaceuticals Recent Developments/Updates
 Table 115. Ataulpho de Paiva Company Information
 Table 116. Ataulpho de Paiva Description and Business Overview
 Table 117. Ataulpho de Paiva BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Ataulpho de Paiva BCG Tuberculosis Vaccine Product
 Table 119. Ataulpho de Paiva Recent Developments/Updates
 Table 120. IVAC – Institute of Vaccines and Medical Biologicals Company Information
 Table 121. IVAC – Institute of Vaccines and Medical Biologicals Description and Business Overview
 Table 122. IVAC – Institute of Vaccines and Medical Biologicals BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. IVAC – Institute of Vaccines and Medical Biologicals BCG Tuberculosis Vaccine Product
 Table 124. IVAC – Institute of Vaccines and Medical Biologicals Recent Developments/Updates
 Table 125. Queen Saovabha Mem. Inst Company Information
 Table 126. Queen Saovabha Mem. Inst Description and Business Overview
 Table 127. Queen Saovabha Mem. Inst BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Queen Saovabha Mem. Inst BCG Tuberculosis Vaccine Product
 Table 129. Queen Saovabha Mem. Inst Recent Developments/Updates
 Table 130. Microgen Company Information
 Table 131. Microgen Description and Business Overview
 Table 132. Microgen BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Microgen BCG Tuberculosis Vaccine Product
 Table 134. Microgen Recent Developments/Updates
 Table 135. Fundação Ataulpho de Paiva Company Information
 Table 136. Fundação Ataulpho de Paiva Description and Business Overview
 Table 137. Fundação Ataulpho de Paiva BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Fundação Ataulpho de Paiva BCG Tuberculosis Vaccine Product
 Table 139. Fundação Ataulpho de Paiva Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. BCG Tuberculosis Vaccine Distributors List
 Table 143. BCG Tuberculosis Vaccine Customers List
 Table 144. BCG Tuberculosis Vaccine Market Trends
 Table 145. BCG Tuberculosis Vaccine Market Drivers
 Table 146. BCG Tuberculosis Vaccine Market Challenges
 Table 147. BCG Tuberculosis Vaccine Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of BCG Tuberculosis Vaccine
 Figure 2. Global BCG Tuberculosis Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global BCG Tuberculosis Vaccine Market Share by Type: 2024 & 2031
 Figure 4. BCG Immunization Product Picture
 Figure 5. BCG Treatment Product Picture
 Figure 6. Global BCG Tuberculosis Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global BCG Tuberculosis Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. Global BCG Tuberculosis Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global BCG Tuberculosis Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global BCG Tuberculosis Vaccine Sales (2020-2031) & (K Units)
 Figure 14. Global BCG Tuberculosis Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 15. BCG Tuberculosis Vaccine Report Years Considered
 Figure 16. BCG Tuberculosis Vaccine Sales Share by Manufacturers in 2024
 Figure 17. Global BCG Tuberculosis Vaccine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest BCG Tuberculosis Vaccine Players: Market Share by Revenue in BCG Tuberculosis Vaccine in 2024
 Figure 19. BCG Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global BCG Tuberculosis Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America BCG Tuberculosis Vaccine Sales Market Share by Country (2020-2031)
 Figure 22. North America BCG Tuberculosis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 23. United States BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe BCG Tuberculosis Vaccine Sales Market Share by Country (2020-2031)
 Figure 26. Europe BCG Tuberculosis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific BCG Tuberculosis Vaccine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific BCG Tuberculosis Vaccine Revenue Market Share by Region (2020-2031)
 Figure 34. China BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America BCG Tuberculosis Vaccine Sales Market Share by Country (2020-2031)
 Figure 44. Latin America BCG Tuberculosis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa BCG Tuberculosis Vaccine Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa BCG Tuberculosis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE BCG Tuberculosis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of BCG Tuberculosis Vaccine by Type (2020-2031)
 Figure 54. Global Revenue Market Share of BCG Tuberculosis Vaccine by Type (2020-2031)
 Figure 55. Global BCG Tuberculosis Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of BCG Tuberculosis Vaccine by Application (2020-2031)
 Figure 57. Global Revenue Market Share of BCG Tuberculosis Vaccine by Application (2020-2031)
 Figure 58. Global BCG Tuberculosis Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 59. BCG Tuberculosis Vaccine Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global BCG Vaccination Market Research Report 2025
Global Tuberculosis Vaccination Market Research Report 2025
Global BCG Vaccine Market Insights Forecast to 2030
TB Vaccine Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
VPM1002 Tuberculosis BCG Based Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bacille Calmette Guerin Vaccine Market Research Report 2024
BCG Tuberculosis TB Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tuberculosis Prevention and Treatment Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global BCG Vaccine for Tuberculosis TB Market Research Report 2025
Global TB Disease Vaccine Market Research Report 2025
Global TB Vaccines Market Insights Forecast to 2030
Global Bacillus Calmette Guerin Vaccine Market Research Report 2025
Global Tuberculosis Vaccines Market Research Report 2024
Global Tuberculosis Vaccine for Vhildren Market Research Report 2024
Tuberculosis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tuberculosis TB Diagnostics Market Research Report 2025
Global Mycobacterium Tuberculosis Testing Market Research Report 2024
Global Tuberculosis TB Detection Market Research Report 2024
Tuberculosis Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions